The present invention relates to a thienopyrrole compound represented by the following formula [I]
wherein each symbol is as defined in the specification, or a pharmaceutically acceptable a salt thereof, and a hepatitis C virus (HCV) polymerase inhibitor and a therapeutic agent for hepatitis C containing this compound as an active ingredient. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.
本发明涉及一种由下式[I]所表示的噻
吡咯烷化合物,其中每个符号如规范中定义,或其药学上可接受的盐,以及一种丙型肝炎病毒(HCV)聚合酶
抑制剂和含有该化合物作为活性成分的治疗剂。本发明的化合物基于HCV聚合酶抑制活性显示抗HCV活性,并且可用作丙型肝炎的预防或治疗剂。